Placebo-controlled trial of cytisine for smoking cessation.
BACKGROUND: Cytisine, a partial agonist that binds with high affinity to the α(4)β(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS: We conducted a...
Asıl Yazarlar: | West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, Stapleton, J |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2011
|
Benzer Materyaller
-
Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
Yazar:: Aveyard, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009) -
Cytisine and the failure to market and regulate for human health.
Yazar:: Aveyard, P, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Potential uses of cytisine for smoking cessation in menopausal women – literature summary
Yazar:: Francisco Rubio Rubio, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01) -
Cytisine versus varenicline for smoking cessation in a primary care setting: a randomized non-inferiority trial
Yazar:: Oreskovic, T, ve diğerleri
Baskı/Yayın Bilgisi: (2023) -
Cancer and smoking cessation
Yazar:: Magdalena Cedzynska, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)